These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9082841)

  • 1. [Mechanism of action of vinpocetine].
    Kiss B; Kárpáti E
    Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D
    Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes.
    Sitges M; Galván E; Nekrassov V
    Neurochem Int; 2005 Jun; 46(7):533-40. PubMed ID: 15843047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studying cGMP-dependent mechanisms of vinpocetine effect on smooth muscle cells].
    Kovalev IV; Baskakov MB; Popov AG; Kilin AA; Minochenko IL; Borodin IuL; Panov AA; Afinogenova IaD; Kapilevich LV; Medvedev MA
    Eksp Klin Farmakol; 2003; 66(4):25-8. PubMed ID: 14558347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
    Horváth S
    Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
    Sitges M; Chiu LM; Nekrassov V
    Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroprotective effect of sodium channel blockers in ischemia: the pathomechanism of early ischemic dysfunction].
    Adám-Vizi V
    Orv Hetil; 2000 Jun; 141(23):1279-86. PubMed ID: 10905082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide.
    Nie SD; Hu CP; Chen YR; Wang S; Deng HW; Li YJ
    Int J Cardiol; 2008 Apr; 125(3):436-8. PubMed ID: 17804099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
    Zhou X; Dong XW; Crona J; Maguire M; Priestley T
    J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.
    Hagiwara M; Endo T; Hidaka H
    Biochem Pharmacol; 1984 Feb; 33(3):453-7. PubMed ID: 6322804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eburnamine derivatives and the brain.
    Vas A; Gulyás B
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
    Deshmukh R; Sharma V; Mehan S; Sharma N; Bedi KL
    Eur J Pharmacol; 2009 Oct; 620(1-3):49-56. PubMed ID: 19699735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
    Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
    Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide-dependent phosphodiesterases (PDEI) inhibition by muscarinic antagonists in bovine tracheal smooth muscle.
    Guerra de González L; González de Alfonzo R; Lippo de Bécemberg I; Alfonzo MJ
    Biochem Pharmacol; 2004 Aug; 68(4):651-8. PubMed ID: 15276072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
    Brain Res Bull; 2000 Oct; 53(3):245-54. PubMed ID: 11113577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.
    Sitges M; Nekrassov V
    Neurochem Res; 1999 Dec; 24(12):1585-91. PubMed ID: 10591410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of vinpocetine on cerebral circulation in rats after exposure to radiation].
    Vereshchagin VK
    Eksp Klin Farmakol; 2003; 66(5):14-6. PubMed ID: 14650207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.